CAPTRUST FINANCIAL ADVISORS - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$77,000
+381.2%
6,690
+441.7%
0.00%
Q1 2022$16,000
+23.1%
1,235
+13.0%
0.00%
Q4 2021$13,000
+44.4%
1,093
+56.4%
0.00%
Q3 2021$9,000
-10.0%
699
-7.0%
0.00%
Q2 2021$10,000
-76.2%
752
-79.8%
0.00%
Q1 2021$42,000
+4100.0%
3,722
+7057.7%
0.00%
Q4 2020$1,000520.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders